Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299,720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86.
Yang S, Yu Y, Jian F, Song W, Yisimayi A, Chen X, Xu Y, Wang P, Wang J, Yu L, Niu X, Wang J, Xiao T, An R, Wang Y, Gu Q, Shao F, Jin R, Shen Z, Wang Y, Cao Y. Yang S, et al. Among authors: wang j, wang y, wang p. Lancet Infect Dis. 2023 Nov;23(11):e457-e459. doi: 10.1016/S1473-3099(23)00573-X. Epub 2023 Sep 19. Lancet Infect Dis. 2023. PMID: 37738994 No abstract available.
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.
Yang S, Yu Y, Xu Y, Jian F, Song W, Yisimayi A, Wang P, Wang J, Liu J, Yu L, Niu X, Wang J, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Yang S, et al. Among authors: wang j, wang y, wang p. Lancet Infect Dis. 2024 Feb;24(2):e70-e72. doi: 10.1016/S1473-3099(23)00744-2. Epub 2023 Dec 15. Lancet Infect Dis. 2024. PMID: 38109919 No abstract available.
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding.
Jian F, Feng L, Yang S, Yu Y, Wang L, Song W, Yisimayi A, Chen X, Xu Y, Wang P, Yu L, Wang J, Liu L, Niu X, Wang J, Xiao T, An R, Wang Y, Gu Q, Shao F, Jin R, Shen Z, Wang Y, Wang X, Cao Y. Jian F, et al. Among authors: wang x, wang l, wang j, wang y, wang p. PLoS Pathog. 2023 Dec 20;19(12):e1011868. doi: 10.1371/journal.ppat.1011868. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38117863 Free PMC article.
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1.
Yang S, Yu Y, Jian F, Yisimayi A, Song W, Liu J, Wang P, Xu Y, Wang J, Niu X, Yu L, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Yang S, et al. Among authors: wang j, wang y, wang p. Emerg Microbes Infect. 2024 Dec;13(1):2343909. doi: 10.1080/22221751.2024.2343909. Epub 2024 May 2. Emerg Microbes Infect. 2024. PMID: 38616729 Free PMC article.
SARS-CoV-2 Neutralizing Antibodies 2.0.
Wang Y. Wang Y. Viruses. 2024 Nov 19;16(11):1791. doi: 10.3390/v16111791. Viruses. 2024. PMID: 39599905 Free PMC article.
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials.
Yang J, Hong W, Shi H, He C, Lei H, Zhou Y, Yang H, Alu A, Chen Z, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Li J, Yang L, Wang W, Shen G, Yang J, Zhao Z, Song X, Su Z, Wei Y, Sun Q, Lu S, Wang Z, Wang Y, Lu G, Li W, Wei X. Yang J, et al. Among authors: wang w, wang j, wang z, wang y. Nat Commun. 2024 Dec 30;15(1):10778. doi: 10.1038/s41467-024-55087-z. Nat Commun. 2024. PMID: 39738039 Free PMC article. Clinical Trial.
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants.
Lei H, Hong W, Yang J, He C, Zhou Y, Zhang Y, Alu A, Shi J, Liu J, Qin F, Ao D, Huang X, Chen Z, Yang H, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Li J, Yang L, Wang Z, Wang W, Shen G, Yang J, Zhao Z, Song X, Lu G, Sun Q, Wang Y, Lu S, Wei X. Lei H, et al. Among authors: wang w, wang j, wang z, wang y. Signal Transduct Target Ther. 2024 Nov 20;9(1):311. doi: 10.1038/s41392-024-02025-6. Signal Transduct Target Ther. 2024. PMID: 39562542 Free PMC article.
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.
Hong W, Lei H, Peng D, Huang Y, He C, Yang J, Zhou Y, Liu J, Pan X, Que H, Alu A, Chen L, Ai J, Qin F, Wang B, Ao D, Zeng Z, Hao Y, Zhang Y, Huang X, Ye C, Fu M, He X, Bi Z, Han X, Luo M, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Wang W, Lu G, Shen G, Yang L, Yang J, Li J, Wang Z, Song X, Sun Q, Lu S, Wang Y, Cheng P, Wei X. Hong W, et al. Among authors: wang w, wang z, wang y, wang b. MedComm (2020). 2024 Apr 27;5(5):e539. doi: 10.1002/mco2.539. eCollection 2024 May. MedComm (2020). 2024. PMID: 38680520 Free PMC article.
299,720 results
You have reached the last available page of results. Please see the User Guide for more information.